Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
6   What's New
Search
International Psoriasis Council
subscribe
Search

Advancing Knowledge. Improving Care.

Digital Health and Psoriasis

IMPROVING ACCESS TO EFFECTIVE TREATMENTS, TIMELY DIAGNOSIS, AND OPTIMAL CARE

Project Description

To date, digital health and telemedicine has been largely focused on “first contact visits.” Psoriasis presents unique challenges, including the need for long-term management. Digital health offers opportunities to develop novel approaches such as exploring artificial intelligence (AI) solutions and the personal management of psoriasis care. IPC convened a working group to establish a road map for how IPC can aid the development and implementation of digital health and telemedicine focused on psoriasis diagnosis and management. he digital health working group, chaired by Andrew Blauvelt and co-chaired by George Han, has completed a global consensus statement regarding telemedicine in psoriasis management, considering cultural and technological differences. Additional activities will include: defining best practices for using telemedicine in treating psoriasis, educating dermatologists on both the opportunities and limitations of telemedicine, and conducting research to understand better the barriers to care based on current reimbursement policies on a global level. 

Project Leaders

Andrew

Blauvelt

,

MD, MBA

Blauvelt Consulting, LLC

Annapolis

,

Maryland

,

United States

IPC Board Member
Bio

George

Han

,

MD, PhD

Zucker School of Medicine at Hofstra/Northwell and Icahn School of Medicine at Mount Sinai

New York

,

New York

,

United States

IPC Councilor
Bio

Working Group Members

  • Daniela Armijo, Chile
  • Kevin Cooper, United States
  • Lucas Galimany, Chile
  • Netsanet Gebeyehu, Ethiopia
  • Paolo Gisondi, Italy
  • Mohammad Huq, Bangladesh
  • Satveer Mahil, United Kingdom
  • Alexander Navarini, Switzerland
  • Lev Pavlovsky, Israel
  • Dharshini Sathishkumar, India
  • Ron Vender, Canada

View more resources on digital health.

MORE

ABSTRACT

During the past few decades, classical in‐person communication has been enriched by opportunities for telemedicine. We are in a learning healthcare environment that takes advantage of the opportunities of telemedicine and in‐person consultations, reconciling the individuality of the patient and his/her psoriasis. A working group of experts in telemedicine was installed by the International Psoriasis Council (IPC) to formulate the opportunities and limitations of telemedicine in the diagnosis and treatment of psoriasis. The working group formulated statements on various aspects of telemedicine according to the nominal group technique to reach a consensus on these statements and explore the variation of opinions. Thirty‐six statements regarding teledermatology and psoriasis were agreed upon by the IPC working group. The value and necessity for the implementation of teledermatology in dermatologic healthcare practices for psoriasis are essential. Management of psoriasis through teledermatology is feasible with a few exceptions. In this communication, the statements are presented and discussed in the context of the available literature, and finally, a call to action by IPC is formulated related to these statements.

Link to article

CLOSE

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.

Name(Required)

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026